Truist analyst Samuel Brodovsky lowered the firm’s price target on SI-Bone to $31 from $33 and keeps a Buy rating on the shares. The company reported another “solid quarter”, though the firm is updating its model to reflect the higher share count from the recent equity raise, the analyst tells investors in a research note. SI-Bone has multiple growth levers in place to sustain momentum into 2024, the firm adds.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on SIBN:
- SI-Bone raises FY23 revenue view to $132M-$134M from $128M-$131M
- SI-Bone reports Q2 EPS (30c), consensus (40c)
- SI-BONE, Inc. Reports Financial Results for the Second Quarter 2023 and Increases Annual Guidance
- Si-Bone (SIBN) Q2 Earnings Cheat Sheet
- SI-BONE to Present at Canaccord Genuity 43rd Annual Growth Conference on August 9, 2023